25 Firmen mit Ergebnissen für "怎么查酒店开房信息- 查询微信dose"

University of Zurich

https://www.campus-schlieren.uzh.ch/en.html  

8952 Schlieren, Wagistrasse 12

The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.

University of Zurich

Wagistrasse 12

8952 Schlieren

300 Ergebnisse für "怎么查酒店开房信息- 查询微信dose" unter University of Zurich

Microsoft Word - 05_2007101800709203_FullPaper_查.doc

... Microsoft Word - 05_2007101800709203_FullPaper_ .doc A MODELING APPROACH FOR STUDYING FOREST ... Microsoft Word - 05_2007101800709203_FullPaper_ .doc ... Microsoft Word - 05_2007101800709203_FullPaper_ .doc A MODELING APPROACH FOR STUDYING FOREST ... Microsoft Word - 05_2007101800709203_FullPaper_ .doc ...

Dose-dependent effects of peroxisome proliferator-activated recepto...

... Maintenance Infos Dose-dependent effects of peroxisome proliferator-activated receptors β/δ agonist ... Griensven, Martijn ; Teuben, Michel ; Hildebrand, Frank ; Pape, Hans-Christoph ; Pfeifer, Roman (2018). Dose ... Dose-dependent effects of peroxisome proliferator-activated receptors β/δ agonist on systemic ... Dose-dependent effects of peroxisome proliferator-activated receptors β/δ agonist on systemic ... Dose-dependent effects of peroxisome proliferator-activated receptors β/δ agonist on systemic ...

Mehr Ergebnisse

Somagenetix

https://www.wysszurich.ch/projects/somagenetix  

8952 Schlieren, Wagistrasse 23

Gene therapy solutions for patients with severe inherited diseases.

Somagenetix

Wagistrasse 23

8952 Schlieren

916 Ergebnisse für "怎么查酒店开房信息- 查询微信dose" unter Somagenetix

Some problems in research work of combined traditional Chinese and ...

... 要 看的页面不存在,请尝试以下操作: 1、如果您已经在地址栏中输入该网页的地址,请确认其拼写正确。 2、单击 后退 按钮,尝试其他链接。 3、打 网站主页,然后 找指向您感兴趣 的链接。 4、联系 ... 网站主页,然后 找指向您感兴趣 的链接。 4、联系网站管理员,报告您访问的错误链接,我们将及时修正。 Item Type: Journal Article, refereed, original ... Additional indexing Other titles: 您要 看的页面不存在,请尝试以下操作: 1、如果您已经在地址栏中输入该网页的地址,请确认其拼写正确。 2、单击 后退 按钮,尝试其他链接。 3、打 ...

被笑恐懼相關特質的測量與 信度及效度之評估 - Zurich Open Repository and Archive

... 被笑恐懼相關特質的測量與 度及效度之評估 - Zurich Open Repository and Archive ... 被笑恐懼相關特質的測量與 度及效度之評估 - Zurich Open Repository and Archive Header Quicknavigation Home Navigation ... 被笑恐懼相關特質的測量與 度及效度之評估 - Zurich Open Repository and Archive ...

Mehr Ergebnisse

Roche Glycart AG

https://www.roche.ch/en/sites/schlieren  

8952 Schlieren, Wagistrasse 10

 +41 43 215 10 00

The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.

Roche Glycart AG

Wagistrasse 10

8952 Schlieren

169 Ergebnisse für "怎么查酒店开房信息- 查询微信dose" unter Roche Glycart AG

腫瘍微小環境 | ロシュ・ダイアグノスティックス

... 腫瘍 小環境 | ロシュ・ダイアグノスティックス ... 腫瘍 小環境 | ロシュ・ダイアグノスティックス あなたはこのサイト上での十分な体験を阻害しうる匿名/プライベートブラウジングモードもしくは広告除去ソフトを使用しているようです。広告除去ソフトを無効 ... 腫瘍 小環境 | ロシュ・ダイアグノスティックス ...

125 years of celebrating life

... 点击 看中文版 Share We’ve been thinking a lot lately about what it means to reach 125 years old in a ... artículo en Español 点击 看中文版 125 years of celebrating life A tradition of improving lives Share We’ve been ...

Mehr Ergebnisse

Molecular Partners AG

http://www.molecularpartners.com  

8952 Schlieren, Wagistrasse 14

 +41 44 755 77 00

Molecular Partners AG is a clinical-stage biopharmaceutical company, located in Schlieren, Switzerland, that is developing a new class of therapies known as DARPin® therapies.

Molecular Partners AG

Wagistrasse 14

8952 Schlieren

84 Ergebnisse für "怎么查酒店开房信息- 查询微信dose" unter Molecular Partners AG

Comments on: Molecular Partners to Present the Completed Phase I Do...

... Comments on: Molecular Partners to Present the Completed Phase I Dose Escalation Interim Results of ... Phase I Dose Escalation Interim Results of MP0250 at the Annual ESMO Congress in Copenhagen Building ... Comments on: Molecular Partners to Present the Completed Phase I Dose Escalation Interim Results of ... http://www.molecularpartners.com/molecular-partners-to-present-the-completed-phase-i- dose ... Comments on: Molecular Partners to Present the Completed Phase I Dose Escalation Interim Results of ...

Molecular Partners reports positive results from its first clinical...

... demonstrated to be dose dependent and to last for most of the patients of the higher dose cohorts for 16 weeks ... demonstrated to be dose dependent and to last for most of the patients of the higher dose cohorts for 16 weeks ... MOLECULAR PARTNERS TO PRESENT THE COMPLETED PHASE I DOSE ESCALATION INTERIM RESULTS OF MP0250 AT THE ANNUAL ...

Mehr Ergebnisse

Neurimmune Therapeutics AG

http://www.neurimmune.com  

8952 Schlieren, Wagistrasse 18

 +41 44 755 46 46
 info@neurimmune.com

Neurimmune is a biopharmaceutical company dedicated to the development of immunotherapeutics for the treatment and prevention of human disorders with a focus on protein aggregation diseases.

Neurimmune Therapeutics AG

Wagistrasse 18

8952 Schlieren

55 Ergebnisse für "怎么查酒店开房信息- 查询微信dose" unter Neurimmune Therapeutics AG

Neurimmune - 12.01.2015: Aducanumab (BIIB037) showed significant ti...

... Neurimmune January 12, 2015 Aducanumab (BIIB037) showed significant time and dose dependent ... amyloid in the brain of AD patients in a time and dose dependent manner and showed an acceptable safety ... Neurimmune - 12.01.2015: Aducanumab (BIIB037) showed significant time and dose dependent reduction ... http://www.neurimmune.com/newsarticle/12012015-aducanumab-biib037-showed-significant-time-and- dose ... Neurimmune - 12.01.2015: Aducanumab (BIIB037) showed significant time and dose dependent reduction ...

Neurimmune - 12.01.2015: Aducanumab (BIIB037) showed significant ti...

... Neurimmune January 12, 2015 Aducanumab (BIIB037) showed significant time and dose dependent ... amyloid in the brain of AD patients in a time and dose dependent manner and showed an acceptable safety ... Neurimmune - 12.01.2015: Aducanumab (BIIB037) showed significant time and dose dependent reduction ... http://www.neurimmune.com/newsartikel/12012015-aducanumab-biib037-showed-significant-time-and- dose ... Neurimmune - 12.01.2015: Aducanumab (BIIB037) showed significant time and dose dependent reduction ...

Mehr Ergebnisse

ETH Entrepreneurship

https://ethz.ch/en/industry/entrepreneurship.html  

8952 Schlieren, Wagistrasse 18


 entrepreneurship@ethz.ch

Excellence in entrepreneurship at ETH Zurich is driven by world-​class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions. 

ETH Entrepreneurship

Wagistrasse 18

8952 Schlieren

79 Ergebnisse für "怎么查酒店开房信息- 查询微信dose" unter ETH Entrepreneurship

Open-Source Software – Mobile Health Systems Lab | ETH Zurich

... /abs/1802.02195call_made DRNets Dose response networks (DRNets) are a method for learning to estimate ... individual dose-response curves for multiple parametric treatments from observational data using neural ... /1802.02195 call_made DRNets Dose response networks (DRNets) are a method for learning to estimate individual ... dose-response curves for multiple parametric treatments from observational data using neural networks ...

Identification of an insect-produced olfactory cue that primes plan...

... overall blend. Furthermore, while the strength of priming is dose dependent, plants respond even to very ... that observed for the overall blend. Furthermore, while the strength of priming is dose dependent ...

Mehr Ergebnisse

Virometix AG

http://virometix.com  

8952 Schlieren, Wagistrasse 14

 +41 (0)43 433 86 60
 info@virometix.com

Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases.

Virometix AG

Wagistrasse 14

8952 Schlieren

5 Ergebnisse für "怎么查酒店开房信息- 查询微信dose" unter Virometix AG

Microsoft Word - Virometix_Press Release-V-306 Phase I Trial-1st Co...

... @virometix.com Virometix Announces Completion of Initial Vaccination of the First Dose Cohort in Phase 1 Study ... first dose cohort in the Phase 1 healthy volunteer study of V-306, its candidate vaccine for prophylaxis ... @virometix.com Virometix Announces Completion of Initial Vaccination of the First Dose Cohort in Phase 1 Study ... first dose cohort in the Phase 1 healthy volunteer study of V-306, its candidate vaccine for prophylaxis ...

... included. V-306 or placebo will be administered by intra-muscular injection as an initial dose, followed by ... a boost dose 56 days later. Subjects will be split into 3 equally sized dose cohorts, with each ... included. V-306 or placebo will be administered by intra-muscular injection as an initial dose, followed by ... a boost dose 56 days later. Subjects will be split into 3 equally sized dose cohorts, with each ...

Mehr Ergebnisse

InSphero AG

http://www.insphero.com  

8952 Schlieren, Wagistrasse 27

 +41 44 515049-0
 info@insphero.com

InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company currently counts all of the top ten global pharmaceutical and cosmetics companies as customers and is helping them to implement its patented microtissue technology in their development work-flow.

InSphero AG

Wagistrasse 27

8952 Schlieren

41 Ergebnisse für "怎么查酒店开房信息- 查询微信dose" unter InSphero AG

... 50 dose, compared to repeat-dosing over 10 days at the max response dose (gray line) or vehicle ... Service Report includes ATP-based dose-response curves Potency (EC 20 Related Services Email* Country ... tumor spheroid growth following single treatment (pulsed-green line) at the EC 50 dose, compared to ... repeat-dosing over 10 days at the max response dose (gray line) or vehicle control (black line). Growth ...

... compounds plus controls (Staurosporine, MEK162, Ipatasertib, Sorafenib/Sunitinib, DMSO) ▬ 11 point dose ... include ▬ ATP-based dose-response curve at day 10 using Promega CellTiter-Glo® ▬ Size-based dose-response ... compounds plus controls (Staurosporine, MEK162, Ipatasertib, Sorafenib/Sunitinib, DMSO) ▬ 11 point dose ... include ▬ ATP-based dose-response curve at day 10 using Promega CellTiter-Glo® ▬ Size-based dose-response ...

Mehr Ergebnisse

University Hospital Zurich​, Research and Education Office

https://www.usz.ch/forschung/Seiten/default.aspx  

8091 Zürich, Rämistrasse 100

The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.

University Hospital Zurich​, Research and Education Office

Rämistrasse 100

8091 Zürich

147 Ergebnisse für "怎么查酒店开房信息- 查询微信dose" unter University Hospital Zurich​, Research and Education Office

Zürich.Diagnosis.Treatment.

... •  Open label, multi-center, multi- dose, dose escalation study •  Results (n=29) show up to 96% TTR ... stabilizers Dose Response and Duration of TTR Knockdown Wild Type vs. Mutant *Excludes post-day 28 data from ... •  Open label, multi-center, multi- dose, dose escalation study •  Results (n=29) show up to 96% TTR ... stabilizers Dose Response and Duration of TTR Knockdown Wild Type vs. Mutant *Excludes post-day 28 data from ...

... . Baumgartl 01.11.2019 CK-Bio Dose Rate and Fractionation M. Pruschy 6.12.2019 CC-Med Sarcoma M. Brown ... . Baumgartl 01.11.2019 CK-Bio Dose Rate and Fractionation M. Pruschy 6.12.2019 CC-Med Sarcoma M. Brown ...

Mehr Ergebnisse

Blutspende SRK Zürich

https://www.blutspendezuerich.ch/  

8952 Schlieren, Rütistrasse 19

 +41 58 272 52 52
 info@zhbsd.ch

The Zurich Blood Transfusion Service SRK (ZHBSD) is a nonprofit foundation and independent partner in the healthcare sector. It ensures the supply of blood and blood products to patients in the Zurich region. Our products are made exclusively from voluntary, unpaid blood donations. We offer our services at cost-covering prices and without government subsidies. Along with ten other regional blood donation services in Switzerland, we are a member of the Swiss Red Cross Blood Donation Service (BSD SRK AG).

Blutspende SRK Zürich

Rütistrasse 19

8952 Schlieren

36 Ergebnisse für "怎么查酒店开房信息- 查询微信dose" unter Blutspende SRK Zürich

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

... , 21 days apart, of either placebo or the BNT162b2 vaccine candidate (30 μg per dose). BNT162b2 is a ... cases of Covid-19 with onset at least 7 days after the second dose among participants as- signed to ... , 21 days apart, of either placebo or the BNT162b2 vaccine candidate (30 μg per dose). BNT162b2 is a ... cases of Covid-19 with onset at least 7 days after the second dose among participants as- signed to ...

2011_Goslings_ISBT Lisboa_Intercept

... thorough analysis of the end-products in terms of volume, platelet dose and amount of contaminating cells ... amotosalen were determined. Results: For PCBC (n=7) the mean platelet dose before INTERCEPT was 4.0x1011 ... thorough analysis of the end-products in terms of volume, platelet dose and amount of contaminating cells ... amotosalen were determined. Results: For PCBC (n=7) the mean platelet dose before INTERCEPT was 4.0x1011 ...

Mehr Ergebnisse

Mehr Firmen

Nach oben